Histopathology of Third Trimester Placenta from SARS-CoV-2-Positive Women

Mai He,Priya Skaria,Kasey Kreutz,Ling Chen,Ian S. Hagemann,Ebony B. Carter,Indira U. Mysorekar,D. Michael Nelson,John Pfeifer,Louis P. Dehner
DOI: https://doi.org/10.1080/15513815.2020.1828517
2020-10-12
Fetal and Pediatric Pathology
Abstract:<span>This study aims to investigate whether maternal SARS-CoV-2 status affects placental pathology. <b>Methods:</b> A retrospective case-control study was conducted by reviewing charts and slides of placentas delivered between April 1 to July 24, 2020. Clinical history of "COVID-19" was searched in Pathology Database (CoPath). Controls were matched with SARS-CoV-2-negative women with singleton deliveries in the 3<sup>rd</sup>-trimester. Pathological features were extracted from placental pathology reports. <b>Results:</b> Twenty-one 3<sup>rd</sup> trimester placentas from SARS-CoV-2-positive women were identified and compared to 20 placentas from SARS-CoV-2-negative women. There were no significant differences in individual or group gross or microscopic pathological features. Within the SARS-CoV-2+ group, there are no differences between symptomatic and asymptomatic women. <b>Conclusion:</b> Placentas from SARS-CoV-2-positive women do not demonstrate a specific pathological pattern. Pregnancy complicated with COVID-19 during the 3<sup>rd</sup> trimester does not have a demonstrable effect on placental structure and pathology.</span>
pediatrics,pathology
What problem does this paper attempt to address?